← Leaderboards
Leah J Siskind
University Of Louisville
$4,258,929
Attributed
$4,583,439
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $649K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,583,439 · 6
By mechanism
R01$4,314,230 · 3
P20$217,903 · 2
F31$51,306 · 1
Top collaborators
- Levi J Beverly1 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Zhong-Bin Deng$6,718,989
- Jun Yan$16,605,525
- David Lominadze$5,311,774
- Levi J Beverly$2,600,630
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsApoptosisKidneyCeramidesInjuryIn VitroSphingolipidsCellsSupportive CareIn VivoEnzymesNecrosisCisplatinAcute Renal Failure With Renal Papillary NecrosisKidney CellLeadInnovationBaseNew Therapeutic TargetChronic Kidney FailurePlayRenal FunctionMediatingMetabolism
Grant awards (16)
Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease$649,021
R01 · FY2025 · CA · contact PI
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.$503,160
R01 · FY2023 · DK · contact PI
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.$502,362
R01 · FY2022 · DK · contact PI
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.$501,565
R01 · FY2021 · DK · contact PI
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.$501,565
R01 · FY2020 · DK · contact PI
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.$52,500
R01 · FY2020 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$325,204
R01 · FY2016 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$325,204
R01 · FY2015 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$325,204
R01 · FY2014 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$251,330
R01 · FY2013 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$57,296
R01 · FY2013 · DK · contact PI
Role of Ceramide-induced Kidney Cell Death in Acute Kidney Injury$319,819
R01 · FY2012 · DK · contact PI
THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASE$108,404
P20 · FY2011 · RR · contact PI
THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASE$109,499
P20 · FY2010 · RR · contact PI
Ceramide Channel Formation in Apoptosis in Stroke$26,606
F31 · FY2002 · NS
Ceramide Channel Formation in Apoptosis in Stroke$24,700
F31 · FY2001 · NS